DrugPatentWatch Database Preview
Hetero Labs Ltd Iii Company Profile
What is the competitive landscape for HETERO LABS LTD III, and what generic and branded alternatives to HETERO LABS LTD III drugs are available?
There are four tentative approvals on HETERO LABS LTD III drugs.
Drugs and US Patents for Hetero Labs Ltd Iii
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hetero Labs Ltd Iii | NEVIRAPINE | nevirapine | TABLET;ORAL | 078584-001 | May 22, 2012 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
Hetero Labs Ltd Iii | CITALOPRAM HYDROBROMIDE | citalopram hydrobromide | SOLUTION;ORAL | 201450-001 | Dec 15, 2015 | AA | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
Hetero Labs Ltd Iii | STAVUDINE | stavudine | CAPSULE;ORAL | 078957-002 | Dec 29, 2008 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
Hetero Labs Ltd Iii | LITHIUM CARBONATE | lithium carbonate | CAPSULE;ORAL | 090702-003 | Sep 25, 2009 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.